Aug 10, 2026 08:00AM
May 11, 2026 08:00AM
Feb 26, 2026 08:00AM
Jan 9, 2026 11:29AM
Jan 9, 2026 09:29AM
Dec 4, 2025 08:15AM
Dec 4, 2025 08:15AM Heron Therapeutics Announces Inclusion of APONVIE® (aprepitant) Injectable Emulsion in the Newly Released Fifth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting (PONV)
Nov 4, 2025 08:00AM
Aug 8, 2025 07:45AM
Aug 8, 2025 07:45AM
Aug 8, 2025 07:45AM
May 6, 2025 07:45AM
Feb 27, 2025 07:45AM
Dec 3, 2024 04:43PM Heron Therapeutics (HRTX) Announces US District Court Upheld Validity of CINVANTI Patents
Dec 3, 2024 04:36PM
Nov 12, 2024 07:55AM
Oct 10, 2024 04:08PM
Sep 25, 2024 08:02AM
Sep 25, 2024 08:00AM
Aug 6, 2024 04:05PM
Jul 15, 2024 08:00AM Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System
Jul 2, 2024 08:00AM
May 29, 2024 08:17AM
May 29, 2024 08:05AM
May 7, 2024 08:00AM
Mar 12, 2024 04:05PM
Jan 24, 2024 04:23AM
Jan 23, 2024 08:00PM Heron Therapeutics Announces FDA Approval of ZYNRELEF® Indication Expansion to Include Additional Orthopedic and Soft Tissue Procedures
Jan 8, 2024 05:23AM
Jan 7, 2024 05:00PM
Dec 22, 2023 04:48PM
Nov 14, 2023 04:05PM
Aug 14, 2023 04:05PM
May 11, 2023 04:01PM
Apr 20, 2023 09:00AM Heron Therapeutics Announces Commercial Leadership Changes
Apr 3, 2023 09:03AM
Apr 3, 2023 09:00AM
Mar 23, 2023 04:05PM
Mar 13, 2023 09:00AM
Mar 6, 2023 09:02AM
Mar 6, 2023 09:00AM
Feb 22, 2023 09:00AM Heron Therapeutics Enters into Cooperation Agreement with Rubric Capital and Velan Capital
Jan 9, 2023 08:30AM
Dec 29, 2022 09:01AM
Dec 29, 2022 09:00AM
Nov 8, 2022 04:05PM
Sep 16, 2022 03:09PM
Sep 16, 2022 02:49PM
Aug 9, 2022 08:01AM Heron Therapeutics (HRTX) Announces 16.13M Share Private Placement at $3.10/sh
Aug 9, 2022 08:01AM

329,204 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All